Maurizio Martelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience	LEUKEMIA & LYMPHOMA	2021
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up	LEUKEMIA & LYMPHOMA	2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects	BRITISH JOURNAL OF HAEMATOLOGY	2021
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up	LEUKEMIA & LYMPHOMA	2021
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab	ANNALS OF HEMATOLOGY	2021
Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia	BLOOD	2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma	BLOOD ADVANCES	2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment	BLOOD ADVANCES	2021
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA	BLOOD ADVANCES	2021
Asciminib: an investigational agent for the treatment of chronic myeloid leukemia	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2021
Measuring prognosis in chronic myeloid leukemia: what's new?	EXPERT REVIEW OF HEMATOLOGY	2021
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2021
Measuring prognosis in chronic myeloid leukemia: what's new?	EXPERT REVIEW OF HEMATOLOGY	2021
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols	ACTA ONCOLOGICA	2021
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study	IN VIVO	2020
Effect of low or high doses of low‐molecular‐weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID‐19	BRITISH JOURNAL OF HAEMATOLOGY	2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma	HEMATOLOGICAL ONCOLOGY	2020